Drug Trial Radar · NCT06126614
Infection Prophylaxis in Total Joint Replacement
Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
21,006
Planned (sponsor's estimate)
Start
May 7, 2024
Primary completion
Nov 2028
Study completion Nov 2028
Sponsor
- Lead sponsor
- Hamilton Health Sciences CorporationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- McMaster University; Ontario Clinical Oncology Group (OCOG)
- First posted
- Nov 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Osteoarthritis (OA) is the most common cause of disability in older adults worldwide affecting 7% of the global population, or more than 500 million people globally. Total joint replacements (TJR) can help bring relief to those with osteoarthritis when other treatment options are no longer helpful. Infection is the main reason hip and knee replacements "fail". Failure leads to repeat surgeries that are often more complicated and less likely to be successful than the first surgery. Reducing the risk of infection is extremely important, antiseptic washes and antibiotics may help us do that. After joint replacement surgery, orthopaedic surgeons wash and clean the surgical wound to lower the risk of infection. The goal of this clinical trial is to determine if the use of antiseptic solutions to wash the surgical site and placing an antibiotic directly into the wound will reduce the number of infections requiring reoperation. Patients having total joint replacements will be randomized (like flipping a coin) to receive 6 possible combinations of washes and / or antibiotics. Participants will be followed for one year after TJR to compare the rate of infection in each group.
Conditions
- Periprosthetic Joint Infection
Interventions
Chlorhexidine GluconateDrug
0.05% chlorhexidine gluconate solution for irrigation
Vancomycin HydrochlorideDrug
2 grams of topical vancomycin hydrochloride added to the wound
Povidone-IodineOther
0.35% povidone-iodine solution for irrigation
SalineOther
saline for irrigation
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number of reoperations due to infectionTime frame: Within 1 year of total joint replacement
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hamilton Health Sciences - Juravinski Hospital and Cancer Centre
Hamilton, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.